Here we show information from a case–control study performed in Argentina, being the first study on sporadic AD genetics in South America, beyond APOE. Our results strongly suggest that rare coding variants described by IGAP in TREM2, PLCG2, and ABI3 might also modulate the susceptibility to AD in this population. This evidence concerns the gene APOE and Alzheimer disease.